161 related articles for article (PubMed ID: 24972773)
1. Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.
Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Royo C; Navarro A; Pinyol M; Rozman M; Pereira A; Villamor N; Aymerich M; López C; Carrió A; Montserrat E
Haematologica; 2014 Oct; 99(10):1599-604. PubMed ID: 24972773
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Amaya-Chanaga CI; Rassenti LZ
Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Schwager SM; Bowen DA; Conte M; Jelinek DF; Slager SL; Shanafelt TD
Haematologica; 2014 Jan; 99(1):140-7. PubMed ID: 23911703
[TBL] [Abstract][Full Text] [Related]
4. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
5. CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.
Del Poeta G; Del Principe MI; Zucchetto A; Luciano F; Buccisano F; Rossi FM; Bruno A; Biagi A; Bulian P; Maurillo L; Neri B; Bomben R; Simotti C; Coletta AM; Dal Bo M; de Fabritiis P; Venditti A; Gattei V; Amadori S
Haematologica; 2012 Feb; 97(2):279-87. PubMed ID: 21993667
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
[TBL] [Abstract][Full Text] [Related]
7. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
Oliveira AC; de la Banda E; Domingo-Domenech E; Encuentra M; Mercadal S; Domingo A; Alonso E; Espinet B; Grau J; De Sevilla AF; Gonzalez-Barca E
Leuk Lymphoma; 2011 Mar; 52(3):429-35. PubMed ID: 21323523
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
10. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
11. Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.
Göbel M; Eisele L; Möllmann M; Hüttmann A; Johansson P; Scholtysik R; Bergmann M; Busch R; Döhner H; Hallek M; Seiler T; Stilgenbauer S; Klein-Hitpass L; Dührsen U; Dürig J
PLoS One; 2013; 8(8):e72107. PubMed ID: 24009671
[TBL] [Abstract][Full Text] [Related]
12. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of patients' sex in chronic lymphocytic leukemia.
Catovsky D; Wade R; Else M
Haematologica; 2014 Jun; 99(6):1088-94. PubMed ID: 24658818
[TBL] [Abstract][Full Text] [Related]
14. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
15. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
16. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
17. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
19. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.
Shanafelt TD; Rabe KG; Kay NE; Zent CS; Jelinek DF; Reinalda MS; Schwager SM; Bowen DA; Slager SL; Hanson CA; Call TG
Cancer; 2010 Oct; 116(20):4777-87. PubMed ID: 20578179
[TBL] [Abstract][Full Text] [Related]
20. The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience.
Sevinc M; Karabulut A; Eskazan AE; Catal Tatonyan S; Ozbek U; Soysal T
Lab Med; 2020 May; 51(3):259-264. PubMed ID: 31589746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
